'SkunkWeeks' venture seeks to speed time to market
IDEA Pharma and Mass Innovation Labs have announced a new collaboration aimed at changing the way the pharma industry approaches innovation.
IDEA Pharma and Mass Innovation Labs have announced a new collaboration aimed at changing the way the pharma industry approaches innovation.
Dongying Tiandong Pharmaceutical Co., Ltd does not do enough to ensure the crude heparin it uses is free potentially lethal contaminant OSCS according to the US FDA.
Vetter's new data processing center at its headquarters in Ravensburg, Germany has met all criteria required to meet the European DIN EN 50600 standard.
ROCKET TRIAL DEATHS
The deaths in a trial of Juno Therapeutics’ JCAR015 are most likely product-specific says the CEO of French CAR-T developer TxCell, who rejected the idea that chemotherapy or the CD19 target played a part.
Delivery device with West Pharmaceutical Services has completed the expansion of its plant in Mulhuddart, County Dublin.
Enamine and Pcovery have extended their drug discovery collaboration that focuses on creating new drugs for treating invasive fungal infections.
Arrowhead has abandoned development of therapies which use its Ex1 delivery vehicle, axing multiple clinical trials and sacking staff.
As Phase IV studies are ‘undergoing a revolution,’ a recent report suggests that medical affairs teams are apt to head post-marketing study strategy.
Wearable technology has been making inroads in the clinical trial industry, however several challenges and concerns surrounding lack of experience still stand in the way of increased adoption.